| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |